title: FDA reorganization intended to streamline review process for biologics.
authors.forename: Damaris E
authors.initials: DE
authors.lastname: Christensen
mesh_terms: D001688:Biological Products; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
chemical_list: D001688:Biological Products